1. Home
  2. Browse
  3. PRJCA010856
Accession PRJCA010856
Title Stage IIIB or IV Non-small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
Relevance Medical
Data types Raw sequence reads
Genome sequencing
Organisms Homo sapiens
Homo
Description A Phase Ib Clinical Study to Evaluate the Safety and Efficacy of JMT101 in Combination with Afatinib or Osimertinib in Stage IIIB or IV Non-small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
Sample scope Monoisolate
Release date 2022-07-28
Publication
PubMed ID Article title Journal name DOI Year
37308490 Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer Nature Communications 10.1038/s41467-023-39139-4 2023
Grants
Agency program Grant ID Grant title
No funding support
Submitter Li Zhang (zhangli@sysucc.org.cn)
Organization Sun Yat-sen University Cancer Center
Submission date 2022-07-28

Project Data

Resource name Description
BioSample (463)  show -